Connect with us

Headlines

FDA Approves Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management

The product is expected to be available in the U.S. by the end of 2021.

mm

Published

on

JACKSONVILLE, FL — Johnson & Johnson Vision announced that the U.S. Food and Drug Administration has approved Acuvue Abiliti Overnight Therapeutic Lenses for myopia management.

Abiliti Overnight orthokeratology lenses are designed and fitted to match a patient’s eye based on its unique corneal shape to temporarily reshape the cornea. The product is expected to be available in the U.S. by the end of 2021.

“The FDA approval of Abiliti Overnight lenses marks an important milestone in our commitment to help change the trajectory of eye health,” said Xiao-Yu Song, MD, PhD, global head of research and development, Johnson & Johnson Vision. “We look forward to supporting patients and eye care professionals with comprehensive resources, starting with Abiliti Overnight lenses, and continuing with additional products and services to address myopia management.”

Abiliti Overnight lenses are optimized by the use of corneal topography, refractive error and other measurements connected to an experiential fitting software, FitAbiliti. The FitAbiliti software guides the eyecare professional through the fitting process and recommends a lens with the first fit success rate of about 90%, according to a press release from Johnson & Johnson Vision. The lenses will be available in two different contact lens designs: Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management, and Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management for Astigmatism.

“The prevalence of myopia in children is increasing, and as optometrists we are on the front lines of this epidemic that may threaten the vision of future generations,” said Moshe Mendelson, OD, FIAO. “The FDA approval of Abiliti Overnight lenses will provide eyecare professionals and parents with more options to manage myopia.”

The FDA approval of Abiliti Overnight lenses stems from the collaboration of Johnson & Johnson Vision with Menicon.

Advertisement

Each annual purchase of an Abiliti product will provide a free comprehensive eye health exam to a child in need through Sight For Kids, a joint program from Johnson & Johnson Vision and the Lions Clubs International Foundation.

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular